Jennifer Meldrum

Tune into the latest episode of #BehindtheGrowth with host Imran M[ia]n as we celebrate Simon Tremblay-Larouche B.Ing. MBA, VP of Strategy and Innovation at Sandoz Canada. Simon dives deep into strategies for success across various industries, shedding light on the unique opportunities and challenges within the pharmaceutical sector. Discover why innovation and operational efficiency are crucial in today's fast-evolving market. 🔍💡 He also discusses future trends in pharma, emphasizing the power of building trust and strong relationships to fuel organizational growth. Don't miss his insights on: 💊 Health sector's innovation struggles  🔑 Building versatile skill sets through diverse career paths  🔍 The challenges of achieving consensus in strategy  🤝 How strong relationships boost career success  📈 The critical role of data management in pharma Catch the full episode below and unlock strategies for success! 🎧🔗 Website: https://lnkd.in/dyQ6Qitf  YouTube: https://lnkd.in/d9k9aCMC  Apple: https://lnkd.in/dmJU3zSW  Spotify: https://lnkd.in/dyJ9nMnM #PharmaceuticalIndustry #Pharma #Success #CareerGrowth #InnovationStrategies #StrategiesforSuccess #Canada

47

1 Comment

Today, on World Hepatitis Day, NL Capital Ventures joins the global effort to raise awareness about hepatitis and promote prevention strategies. 🌍🩺 Hepatitis remains a major global health challenge, and increasing awareness is key to combating this disease. Here’s how we contribute to the fight against hepatitis: Education and Awareness: We support educational initiatives that inform communities about the risks of hepatitis and the importance of early detection. Knowledge is the first step towards prevention. 📚💡 #HepatitisAwareness #KnowYourStatus Screening Programs: By promoting regular hepatitis screenings, we help individuals identify and address the condition early, improving treatment outcomes and reducing transmission. 🩺🔬 #HepatitisScreening #EarlyDetection Vaccination Support: We advocate for and support vaccination programs that prevent hepatitis B and C, which are crucial for reducing the prevalence of these diseases. 💉🌟 #HepatitisPrevention #Vaccination Community Outreach: Our outreach programs provide resources and support to underserved populations, ensuring they have access to necessary health services and information. 🌍🤝 #CommunityHealth #HealthEquity Support for Research: We invest in research initiatives aimed at finding new treatments and ultimately curing hepatitis, contributing to global health advancements. 🧬🔬 #ResearchForACure #HealthcareInnovation At NL Capital Ventures, we are dedicated to raising awareness and supporting efforts to prevent and treat hepatitis. Join us in observing World Hepatitis Day by learning more about this important issue and taking proactive steps towards prevention. Together, we can make a difference in the fight against hepatitis. 🌟🩺 #WorldHepatitisDay #HepatitisAwareness #NLcapitalventures #Prevention #Screening #Vaccination #CommunityHealth #ResearchForACure #HealthEquity #GlobalHealth

6

2 Comments

Q&A with Michel Robidoux of Sandoz Canada CGPA: You’re the Vice-Chair of the CGPA. What’s the most important part of your job? Michel: Making patient care more affordable across the country. Generic medication is as safe and effective as the brand-name versions, but costs significantly less. In fact, some of the most prescribed generic medicines come with a price tag that's 90% lower than the same brand-name medication. That means 10 different patients can be treated for the same cost treating just one patient with the brand-name version, so our work has huge impact on both affordability and access to care. CGPA: And you’re also the President and General Manager of Sandoz Canada, which is headquartered in Quebec. How important is the generic pharmaceutical industry to your province? Michel: Extremely important. The industry employs thousands of Quebecers in life-sciences, technology and manufacturing jobs. These are the kinds of jobs that support our communities and stimulate our economy. CGPA: In our last interview with your colleague, Michael B. Sine, we talked about the fact that Ontario would save more than $409 million dollars if it increased its use of generics by only 1%. How much would Quebec save if it did the same thing? Michel: Next to Ontario, Quebec would stand to save the most by increasing its use of generics. A 1% increase alone would translate to $284 million in savings. Overall, the majority of Quebecers understand the importance of generics and are committed to supporting the industry. In fact, 79% of all prescriptions in Quebec are filled with generic medications—that’s more than any other province in the country. CGPA: Sounds like the rest of Canada could learn a thing or two from the people of Quebec. Michel: Of course! After all, we do have the best food, the best nightlife and the best hockey team. CGPA: I’m sure there are a lot of Toronto Maple Leafs fans who would disagree. Michel: We are all Canadian after all…so let's bring the Cup back to Canada.

51

🇨🇦 British Columbia becomes the #first #province in #Canada to sign a #pharmacare agreement with the federal government that will help fund hormone replacement therapy and #diabetes expenses. 💊💉 📅🏛️Federal #Health #Minister Mark Holland says B.C.'s portion of the $1.5-billion national plan is estimated to be $195 million, and under the memorandum of understanding, funding could begin by April once the legislation makes it through the Senate. The coverage was initially meant for birth control and diabetes drugs and supplies, but B.C. #Health #Minister Adrian Dix notes that oral contraceptives are already covered under a provincial program. 🚼💊 So, that share will now be used to cover #HRT for women. ♀️🔄 🚼💊Dix says about 150,000 British Columbians receive diabetes medications, and it's estimated that covering hormone replacement therapy will benefit 40,000 women. 👩‍⚕️📈 In April 2023, B.C. became the first jurisdiction in Canada to provide free birth control. https://lnkd.in/g3e2BqRi

5

The Power of Connections in the Pharmaceutical Industry Working in the pharmaceutical sector for over 8 years, including 4 years at Sandoz, has taught me the immense value of building strong relationships. Each interaction can lead to new opportunities and insights. As I settle into Ottawa, I’m reflecting on how new connections can open doors and foster collaboration. I’d love to hear how others in this vibrant community have navigated their networking journeys. What strategies have you found effective in creating lasting professional relationships? Looking forward to your thoughts! #Pharmaceuticals #Networking #Ottawa #OttawaBusiness #Connections #CareerGrowth"

6

2 Comments

Do you suffer from asthma? Check out these tips from Hayat Founder Hashim Zaibak, PharmD, about what medications to use and when to better manage your asthma. These messages come on the heels of air quality advisories in our area due to Canadian wildfires. A good reminder to use your inhaler as directed to stay protected. #asthma #AsthmaTreatment #LungHealth #MedicationGoals #HealthMinutewithHashim #heathadvice #hayatpharmacy

32

3 Comments

📊 Statistics Canada's latest analysis of the Canadian Research and Development Pharmaceutical Sector reveals the profound impact the innovative pharmaceutical industry has on Canada's economy. The report highlights how the sector, which includes members of Innovative Medicines Canada, has contributed more than $16 Billion to the Canadian economy in 2021. Not only are our members playing a crucial role in enhancing healthcare to deliver life-saving medicines to Canadians, but also creating more than 100,000 high-value jobs and supporting critical research and innovation. Explore how the industry is contributing to the total health of Canada while fueling economic growth across the country. View the full report here: https://buff.ly/46LSdgj https://buff.ly/46LaaeU #Innovation #CanadianHealthcare #CanadianEconomy

25